![](/img/cover-not-exists.png)
Long-Term Cost-Effectiveness of Pioglitazone versus Placebo in Addition to Existing Diabetes Treatment: A US Analysis Based on PROactive
William J. Valentine, Daniel Tucker, Andrew J. Palmer, Michael E. Minshall, Volker Foos, Cheryl SilbermanVolume:
12
Year:
2009
Language:
english
Pages:
9
DOI:
10.1111/j.1524-4733.2008.00403.x
File:
PDF, 147 KB
english, 2009